Does Buffett's Latest $9.7 Billion Deal Create a Buying Opportunity for Occidental and Berkshire Stock?

Berkshire Hathaway is set to acquire Occidental Petroleum's chemical unit, OxyChem, for $9.7 billion in an all-cash deal expected to close in Q4. This transaction will enable Occidental to immediately repay $6.5 billion in debt, significantly strengthening its balance sheet, though it will also make the company a more pure-play oil and gas producer, increasing its exposure to commodity price volatility. For Berkshire, the acquisition expands its non-insurance chemicals portfolio, strategically deploying a portion of its cash reserves into a cash-generating asset without increasing its direct exposure to volatile energy markets.

Analysis

Berkshire Hathaway's acquisition of Occidental Petroleum's chemical unit, OxyChem, for $9.7 billion in cash marks a significant strategic maneuver for both entities. For Occidental, the transaction is primarily a deleveraging event, enabling the immediate repayment of $6.5 billion in debt incurred from its recent $12 billion CrownRock acquisition. This substantially improves its balance sheet and provides flexibility for future capital returns, such as share repurchases and dividend growth, which increased 22% last year. However, this comes at the cost of divesting a significant asset; OxyChem generated $1.1 billion in operating income, or 16% of Occidental's total, in the last fiscal year. The sale transforms Occidental into a more concentrated oil and gas producer, thereby increasing its earnings sensitivity to commodity price volatility, a risk reflected in the stock's decline following the announcement. For Berkshire Hathaway, this deal represents a strategic deployment of a fraction of its over $340 billion cash pile into its non-insurance portfolio. By acquiring a cash-generative business that complements its existing specialty chemicals operations, Berkshire gains a valuable asset without increasing its direct exposure to the volatile energy markets, a move that contrasts with market expectations of a full takeover of Occidental Petroleum.

Key Decisions for Investors

• Investors in Occidental Petroleum should reassess their holdings in light of the company's heightened exposure to commodity price fluctuations, as it becomes a pure-play oil and gas entity post-divestiture.
• Consider the trade-off for Occidental: the strengthened balance sheet and potential for enhanced capital returns must be weighed against the loss of a stable earnings stream from OxyChem, which contributed 16% of total operating income.
• For Berkshire Hathaway shareholders, the OxyChem acquisition is a positive, low-risk deployment of capital that expands its industrial earnings base with a cash-generative asset, reinforcing its strategy of acquiring quality businesses while prudently managing portfolio risk.